Production (Stage)
Foghorn Therapeutics Inc.
FHTX
$4.32
-$0.22-4.85%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 24.71% | 19.09% | -33.30% | 22.07% | 17.95% |
| Total Depreciation and Amortization | -0.96% | -10.68% | -15.16% | -9.70% | -2.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -18.73% | -40.72% | -45.08% | 25.52% | -18.25% |
| Change in Net Operating Assets | -0.34% | 1.44% | 71.70% | -12.43% | -41.20% |
| Cash from Operations | 18.32% | 10.97% | 22.80% | 20.63% | 5.89% |
| Capital Expenditure | 72.28% | -1,194.59% | -276.83% | 96.38% | 84.12% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 8.21% | -39.16% | -258.43% | -145.35% | -9.77% |
| Cash from Investing | 8.51% | -40.37% | -259.57% | -145.93% | -8.17% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -88.09% | -97.85% | 3.89% | 100,289.32% | 1,044.12% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -88.09% | -97.85% | -24.22% | 100,100.00% | 1,044.12% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 614.50% | -122.17% | -744.84% | 745.28% | 31.15% |